---
schema_version: "secwatch.filing_event.v1"
accession: "0001773751-22-000226"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2022-11-07T23:59:59+00:00"
generated_at: "2026-06-22T05:41:09.795962+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers Q3 revenue $144.8M (+95% YoY); raises FY 2022 guidance; expects Q4 Adj. EBITDA profitability

## Summary
- Revenue of $144.8M, up 95% YoY; net loss $(18.8)M vs $(15.9)M a year ago.
- Adjusted EBITDA improved to $(6.1)M from $(9.8)M; expects Q4 2022 Adjusted EBITDA profitability.
- Subscriptions reached 991,000 (+80% YoY); Q3 net new subscriptions all-time high >170,000.
- Raises FY 2022 revenue guidance to $519-522M; Adjusted EBITDA guidance to $(20)-$(18)M.
- Gross margin expanded to 79% from 74% YoY; net loss improved on adjusted basis.

## SEC filing metadata
- accession: 0001773751-22-000226
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2022-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000177375122000226/0001773751-22-000226-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000177375122000226/hims-20221107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001773751-22-000226
- JSON: https://secwatch.observer/filing/0001773751-22-000226.json
- Plain text: https://secwatch.observer/filing/0001773751-22-000226.txt

## Key facts
- Earnings Releases
  Hims & Hers Health, Inc. reported third quarter ended September 30, 2022 results: revenue Revenue was $144.8 million for the third quarter 2022 compared to $74.2 million for the third quarter 2021, net income Net loss was $(18.8) million for the third quarter 2022 compared to $(15.9) million for the third quarter 2021. Guidance raised.
  - Period: third quarter ended September 30, 2022
  - Revenue: Revenue was $144.8 million for the third quarter 2022 compared to $74.2 million for the third quarter 2021
  - Net income: Net loss was $(18.8) million for the third quarter 2022 compared to $(15.9) million for the third quarter 2021
  - Guidance: raised
  - Result: reported results
  source text: Hims & Hers Health, Inc. Reports Third Quarter 2022 Financial Results and Raises Full Year 2022 Outlook; Platform Demand and Financial Outperformance Driving Expected Adjusted EBITDA Profitability Beginning in Q4 2022 Quarterly revenue of $144.8 million in Q3 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1773751/000177375122000226/0001773751-22-000226-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.